Jounce Therapeutics Inc. (JNCE)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Partner Fund Management

Christopher Medlock James

3,262,833 $22,187 0.69%
2.
Adage Capital Management

Phill Gross And Robert Atchinson

2,428,023 $16,511 0.03%
3.
OrbiMed Advisors

Samuel Isaly

2,147,400 $14,602 +18% 0.14%
4. 1,960,601 $13,332 +1% 0%
5.
Millennium Management

Israel Englander

458,316 $3,117 +158% 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$7.84 1,900 Officer 1,900 2018-06-15 Filing
$16.00 5,000 Director 5,000 2017-02-01 Filing
$16.00 6,700 Director 27,025 2017-02-01 Filing
$16.00 625,000 Large Shareholder 3,456,463 2017-02-01 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$8.00 552,520 Large Shareholder 5,947,829 2021-05-25 Filing
$10.00 200 Director 9,713 2021-04-15 Filing
$12.80 200 Director 9,913 2021-03-15 Filing
$0.00 0 Director 0 2021-03-01 Filing
$11.75 1,450,000 Large Shareholder 7,750,349 2021-03-01 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 25,450 $173,000 0%
2. 4,447,829 $30,245 89.28%
3. 3,303 $22,460 0%
4. 3,048,780 $20,732 3.61%
5. 2,457,099 $16,708 0%
News See All